Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With Chronic Hepatitis C
The purpose of this study is to see which of two doses of PEG (polyethylene glycol) interferon alfa-2b in combination with Ribavirin for 48 weeks is more effective at elimination of hepatitis C.
The primary objective of this study is to compare the efficacy of Induction PEG-Interferon alfa-2b (PEG-Intron) and Ribavirin (Rebetol) to standard PEG-Interferon alfa-2b (PEG-Intron) and Ribavirin (Rebetol) in patients with chronic hepatitis C.
100 Clinical Results associated with T.R.U.E. Research Foundation
0 Patents (Medical) associated with T.R.U.E. Research Foundation
100 Deals associated with T.R.U.E. Research Foundation
100 Translational Medicine associated with T.R.U.E. Research Foundation